+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: Observations on treated and nontreated episodes



Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: Observations on treated and nontreated episodes



Journal of the American College of Cardiology 35(6): 1428-1433



OBJECTIVES: We sought to evaluate the number and duration of device-treated and self-terminating, nontreated episodes of atrial fibrillation (AF) after implantation of the Metrix Atrioverter. BACKGROUND: A recent study has shown that the Atrioverter can rapidly restore sinus rhythm in patients with AF; however, the effect of the device on the clinical course of the arrhythmia in these patients is unknown. METHODS: The Atrioverter was implanted in 51 patients with symptomatic, recurrent, drug-refractory AF. The device was programmed to periodically monitor the cardiac rhythm. Defibrillation of AF episodes was performed under physician observation. RESULTS: During a mean follow-up of 260 +- 144 days, 1,161 episodes of AF were observed during valid monitoring periods in 45 of 51 patients. Forty-one patients experienced 231 episodes for which they sought defibrillation therapy. The average duration of the treated episodes during valid monitoring periods (190 of 231 episodes in 39 of 41 patients) was significantly longer than that of the nontreated episodes (38 +- 44 vs. 10 +- 8 h; p < 0.05). The time between episodes requiring Atrioverter therapy increased, and the risk of having an episode requiring treatment decreased. No changes were observed in the number and duration of the short-lasting, nontreated episodes as time since implantation of the device increased. CONCLUSIONS: In patients with symptomatic, recurrent, drug-refractory AF, the frequency of long-lasting episodes, which were treated under observation with repeated defibrillation using the Atrioverter, decreased. The number and duration of short-lasting, nontreated episodes did not change during the 20-month study period. The effect of ambulatory use of the device on the recurrence of short-lasting episodes needs to be evaluated.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011390155

Download citation: RISBibTeXText

PMID: 10807443

DOI: 10.1016/s0735-1097(00)00579-9


Related references

Number, duration and frequency of non-treated atrial fibrillation episodes observed during the metrix automatic implantable atrial defibrillator trial. European Heart Journal 19(ABST SUPPL ): 258, 1998

Ambulatory use of the Metrix automatic implantable atrial defibrillator to treat episodes of atrial fibrillation. European Heart Journal 19(ABST SUPPL ): 76, 1998

Clinical experience with the implantable atrial defibrillator (atrioverter) in patients with atrial fibrillation. Metrix Investigators. Zeitschrift für Kardiologie 88(8): 574-581, 1999

Modes of onset of spontaneous episodes of atrial fibrillation Implications for the prevention of atrial fibrillation by pacing. Daubert, J C , Prystowsky, E N , Ripart, A Prevention of tachyarrhythmias with cardiac pacing : 53-65, 1997

Analysis of atrial fibrillatory rate during spontaneous episodes of atrial fibrillation in humans using implantable loop recorder electrocardiogram. Journal of Electrocardiology 45(6): 723-726, 2013

Differences between induced and spontaneous episodes of atrial fibrillation in humans. Circulation 100(18 SUPPL ): I 287, Nov 2, 1999

Variability in the mode of spontaneous termination of induced episodes of atrial fibrillation. European Heart Journal 18(ABSTR SUPPL ): 319, 1997

Yoga may help reduce episodes of atrial fibrillation. The calming and balancing effects of yoga may cut down on common triggers for AF episodes and may have other health benefits, too. Heart Advisor 14(6): 7-7, 2013

Atrial fibrillation detection and R-wave synchronization by Metrix implantable atrial defibrillator: implications for long-term efficacy and safety. The Metrix Investigators. Circulation 99(11): 1446-1451, 1999

The Connexin40A96S mutation from a patient with atrial fibrillation causes decreased atrial conduction velocities and sustained episodes of induced atrial fibrillation in mice. Journal of Molecular and Cellular Cardiology 65: 19-32, 2014

Differences in heart rate dynamics before the spontaneous onset of long and short episodes of paroxysmal atrial fibrillation. Annals of Noninvasive Electrocardiology 6(2): 134-142, 2001

Atrial fibrillation in patients with a dual defibrillator: characteristics of spontaneous and induced episodes and effect of ventricular tachyarrhythmia induction. Journal of Cardiovascular Electrophysiology 16(9): 974-980, 2005

Electrophysiological abnormalities occur prior to the development of clinical episodes of atrial fibrillation: observations from human epicardial mapping. Pacing and Clinical Electrophysiology 31(4): 443-453, 2008

Effect of combined spironolactone-β-blocker ± enalapril treatment on occurrence of symptomatic atrial fibrillation episodes in patients with a history of paroxysmal atrial fibrillation (SPIR-AF study). American Journal of Cardiology 106(11): 1609-1614, 2011